195 related articles for article (PubMed ID: 15601469)
1. Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin.
Ravizza R; Gariboldi MB; Passarelli L; Monti E
BMC Cancer; 2004 Dec; 4():92. PubMed ID: 15601469
[TBL] [Abstract][Full Text] [Related]
2. miRNA-29a reverses P-glycoprotein-mediated drug resistance and inhibits proliferation via up-regulation of PTEN in colon cancer cells.
Shi X; Valizadeh A; Mir SM; Asemi Z; Karimian A; Majidina M; Safa A; Yosefi B
Eur J Pharmacol; 2020 Aug; 880():173138. PubMed ID: 32416187
[TBL] [Abstract][Full Text] [Related]
3. Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.
Sankala HM; Hait NC; Paugh SW; Shida D; Lépine S; Elmore LW; Dent P; Milstien S; Spiegel S
Cancer Res; 2007 Nov; 67(21):10466-74. PubMed ID: 17974990
[TBL] [Abstract][Full Text] [Related]
4. Targeted cytotoxic somatostatin analogue AN-238 inhibits somatostatin receptor-positive experimental colon cancers independently of their p53 status.
Szepeshazi K; Schally AV; Halmos G; Armatis P; Hebert F; Sun B; Feil A; Kiaris H; Nagy A
Cancer Res; 2002 Feb; 62(3):781-8. PubMed ID: 11830533
[TBL] [Abstract][Full Text] [Related]
5. p21 Waf1/Cip1 can protect human colon carcinoma cells against p53-dependent and p53-independent apoptosis induced by natural chemopreventive and therapeutic agents.
Mahyar-Roemer M; Roemer K
Oncogene; 2001 Jun; 20(26):3387-98. PubMed ID: 11423989
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic p21 induced by p65 prevents doxorubicin-induced cell death in pancreatic carcinoma cell line.
Zhou Y; Li G; Ji Y; Liu C; Zhu J; Lu Y
J Biomed Sci; 2012 Feb; 19(1):15. PubMed ID: 22305266
[TBL] [Abstract][Full Text] [Related]
7. HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest.
Venkatakrishnan CD; Dunsmore K; Wong H; Roy S; Sen CK; Wani A; Zweier JL; Ilangovan G
Am J Physiol Heart Circ Physiol; 2008 Apr; 294(4):H1736-44. PubMed ID: 18263706
[TBL] [Abstract][Full Text] [Related]
8. Cell death by the quinoxaline dioxide DCQ in human colon cancer cells is enhanced under hypoxia and is independent of p53 and p21.
El-Khatib M; Geara F; Haddadin MJ; Gali-Muhtasib H
Radiat Oncol; 2010 Nov; 5():107. PubMed ID: 21078189
[TBL] [Abstract][Full Text] [Related]
9. NUPR1 interacts with p53, transcriptionally regulates p21 and rescues breast epithelial cells from doxorubicin-induced genotoxic stress.
Clark DW; Mitra A; Fillmore RA; Jiang WG; Samant RS; Fodstad O; Shevde LA
Curr Cancer Drug Targets; 2008 Aug; 8(5):421-30. PubMed ID: 18690848
[TBL] [Abstract][Full Text] [Related]
10. p53 and p21 determine the sensitivity of noscapine-induced apoptosis in colon cancer cells.
Aneja R; Ghaleb AM; Zhou J; Yang VW; Joshi HC
Cancer Res; 2007 Apr; 67(8):3862-70. PubMed ID: 17440101
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines.
Lee TK; Lau TC; Ng IO
Cancer Chemother Pharmacol; 2002 Jan; 49(1):78-86. PubMed ID: 11855756
[TBL] [Abstract][Full Text] [Related]
12. HCT116 cells deficient in p21(Waf1) are hypersensitive to tyrosine kinase inhibitors and adriamycin through a mechanism unrelated to p21 and dependent on p53.
Ferrandiz N; Martin-Perez J; Blanco R; Donertas D; Weber A; Eilers M; Dotto P; Delgado MD; Leon J
DNA Repair (Amst); 2009 Mar; 8(3):390-9. PubMed ID: 19150257
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
14. TNF-alpha promotes Doxorubicin-induced cell apoptosis and anti-cancer effect through downregulation of p21 in p53-deficient tumor cells.
Cao W; Chi WH; Wang J; Tang JJ; Lu YJ
Biochem Biophys Res Commun; 2005 May; 330(4):1034-40. PubMed ID: 15823547
[TBL] [Abstract][Full Text] [Related]
15. Differential response of p53 and p21 on HDAC inhibitor-mediated apoptosis in HCT116 colon cancer cells in vitro and in vivo.
Zopf S; Neureiter D; Bouralexis S; Abt T; Glaser KB; Okamoto K; Ganslmayer M; Hahn EG; Herold C; Ocker M
Int J Oncol; 2007 Dec; 31(6):1391-402. PubMed ID: 17982666
[TBL] [Abstract][Full Text] [Related]
16. The nitroxide Tempol modulates anthracycline resistance in breast cancer cells.
Gariboldi MB; Terni F; Ravizza R; Meschini S; Marra M; Condello M; Arancia G; Monti E
Free Radic Biol Med; 2006 Apr; 40(8):1409-18. PubMed ID: 16631531
[TBL] [Abstract][Full Text] [Related]
17. Role of p21 as a determinant of 1,6-Bis[4-(4-amino-3-hydroxyphenoxy)phenyl] diamantane response in human HCT-116 colon carcinoma cells.
Wang JJ; Hung HF; Huang ML; Lee HJ; Chern YT; Chang YF; Chi CW; Hsu YC
Oncol Rep; 2012 Feb; 27(2):529-34. PubMed ID: 22076474
[TBL] [Abstract][Full Text] [Related]
18. p53-Dependent activation of a molecular beacon in tumor cells following exposure to doxorubicin chemotherapy.
Shah R; El-Deiry WS
Cancer Biol Ther; 2004 Sep; 3(9):871-5. PubMed ID: 15254427
[TBL] [Abstract][Full Text] [Related]
19. The antitumor effect of a novel differentiation inducer, 2, 2-Bis (4-(4-amino-3-hydroxyphenoxy) phenyl) adamantane (DPA), in combinatory therapy on human colon cancer.
Wang JJ; Lee JY; Chen YC; Chern YT; Chi CW
Int J Oncol; 2006 Apr; 28(4):1003-12. PubMed ID: 16525652
[TBL] [Abstract][Full Text] [Related]
20. The anticancer effect of saffron in two p53 isogenic colorectal cancer cell lines.
Bajbouj K; Schulze-Luehrmann J; Diermeier S; Amin A; Schneider-Stock R
BMC Complement Altern Med; 2012 May; 12():69. PubMed ID: 22640402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]